Abnormalities of visual search behaviour in ALS patients detected with event-related brain potentials.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 12365064)

Published in Amyotroph Lateral Scler Other Motor Neuron Disord on December 01, 1999

Authors

T F Münte1, M C Tröger, I Nusser, B M Wieringa, M Matzke, S Johannes, R Dengler

Author Affiliations

1: Department of Neurology, Medical School of Hannover, 30623 Hannover, Germany. muente-thomas@mh-hannover.de

Articles by these authors

Combined spatial and temporal imaging of brain activity during visual selective attention in humans. Nature (1994) 2.89

Dopamine transporter binding in Gilles de la Tourette syndrome. J Neurol (2000) 1.79

Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences. Exp Neurol (1997) 1.61

The use of family health services authority registers as a sampling frame in the UK: a review of theory and practice. J Epidemiol Community Health (1995) 1.58

Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56

Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology (2002) 1.53

The anesthetic propofol modulates gating in paramyotonia congenita mutant muscle sodium channels. Muscle Nerve (2001) 1.53

EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol (2005) 1.45

Retinotopic organization of early visual spatial attention effects as revealed by PET and ERPs. Hum Brain Mapp (1997) 1.45

Unusual presentation of a primary spinal Burkitt's lymphoma. J Neurol Neurosurg Psychiatry (2001) 1.41

Succinamopine: a new crown gall opine. J Bacteriol (1984) 1.39

Two cases of adynamia episodica hereditaria: in vitro investigation of muscle cell membrane and contraction parameters. Muscle Nerve (1983) 1.39

Role of endotoxin in the pathogenesis of critical illness polyneuropathy. J Neurol (2008) 1.39

Preferential elimination of repeated DNA sequences from the paternal, Nicotiana tomentosiformis genome donor of a synthetic, allotetraploid tobacco. New Phytol (2005) 1.35

Molecular and cytogenetic characterization of a transgene locus that induces silencing and methylation of homologous promoters in trans. Plant J (1999) 1.35

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm (Vienna) (2004) 1.26

Brain potentials and syntactic violations revisited: no evidence for specificity of the syntactic positive shift. Neuropsychologia (1998) 1.25

Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosis. Leukemia (2007) 1.22

Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol. Eur J Anaesthesiol (2002) 1.22

Differences in brain potentials to open and closed class words: class and frequency effects. Neuropsychologia (2001) 1.19

Discrepant target detection and action monitoring in obsessive-compulsive disorder. Psychiatry Res (2001) 1.19

Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol (2012) 1.18

Botulinum toxin treatment of cocontractions after birth-related brachial plexus lesions. Neurology (2000) 1.18

A long-term follow-up of botulinum toxin A in cervical dystonia. Neurol Res (2009) 1.17

Receptive amusia: evidence for cross-hemispheric neural networks underlying music processing strategies. Brain (2000) 1.16

The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome. Cerebrovasc Dis (2010) 1.16

Propofol blocks human skeletal muscle sodium channels in a voltage-dependent manner. Anesth Analg (2001) 1.13

Molecular and cytogenetic analyses of stably and unstably expressed transgene loci in tobacco. Plant Cell (1997) 1.13

Transient severe parkinsonism after acute organophosphate poisoning. J Neurol Neurosurg Psychiatry (1999) 1.12

Brain activity associated with syntactic incongruencies in words and pseudo-words. J Cogn Neurosci (1997) 1.11

Membrane defects in paramyotonia congenita with and without myotonia in a warm environment. Muscle Nerve (1981) 1.05

Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J Neuroimmunol (2003) 1.04

High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues. Br J Pharmacol (2008) 1.03

Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Mov Disord (2001) 1.02

Structural requirements of phenol derivatives for direct activation of chloride currents via GABA(A) receptors. Eur J Pharmacol (2001) 1.01

Improved therapy of myotonia with the lidocaine derivative tocainide. J Neurol (1980) 0.99

High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport (2000) 0.99

Botulinum A toxins: units versus units. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.98

Impact of a postcard versus a questionnaire as a first reminder in a postal lifestyle survey. J Epidemiol Community Health (1993) 0.97

Muscle vibration: different effects on transcranial magnetic and electrical stimulation. Muscle Nerve (1999) 0.96

Alteration of early components of the visual evoked potential in amyotrophic lateral sclerosis. J Neurol (1998) 0.96

Altered inhibition of motor responses in Tourette Syndrome and Obsessive-Compulsive Disorder. Acta Neurol Scand (2001) 0.96

Brain potentials reveal the timing of face identity and expression judgments. Neurosci Res (1998) 0.96

Determination of the thermal neutron flux in a fast neutron beam by use of a boron-coated ionization chamber. Med Phys (1995) 0.95

Experimental Escherichia coli epididymitis in rats: a model to assess the outcome of antibiotic treatment. BJU Int (2002) 0.94

Alteration of sensorimotor integration in musician's cramp: impaired focusing of proprioception. Clin Neurophysiol (2000) 0.93

Oxazepam alters action monitoring. Psychopharmacology (Berl) (2001) 0.93

Crossed effects of muscle vibration on motor-evoked potentials. Clin Neurophysiol (2001) 0.93

Poly(adenosine diphosphate-ribose) polymerase in quail oviduct. Changes during estrogen and progesterone induction. Nucleic Acids Res (1974) 0.92

Differential effects of emotional content on event-related potentials in word recognition memory. Neuropsychobiology (2001) 0.92

Discharge pattern of single motor units in basal ganglia disorders. Neurology (1986) 0.92

Evaluation of sampling tools for environmental sampling of bacterial endospores from porous and nonporous surfaces. J Appl Microbiol (2008) 0.90

Use of forward genetic screens to identify genes required for RNA-directed DNA methylation in Arabidopsis thaliana. Cold Spring Harb Symp Quant Biol (2012) 0.90

Kinetic analysis of recombinant mammalian alpha(1) and alpha(1)beta glycine receptor channels. Eur Biophys J (2003) 0.90

Succinylcholine metabolite succinic acid alters steady state activation in muscle sodium channels. Anesthesiology (2000) 0.89

Mood cycles associated with normal pressure hydrocephalus. Am J Psychiatry (1996) 0.89

Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials. World J Urol (2001) 0.89

Differential effects of two motor tasks on ERPs in an auditory classification task: evidence of shared cognitive resources. Neurosci Res (1998) 0.88

Infiltration of the central nervous system by a granulosa cell tumor immunostained by antibodies against inhibin. Neurology (1998) 0.88

Parameters of human motor unit twitches obtained by intramuscular microstimulation. Neuromuscul Disord (1992) 0.87

Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache (2000) 0.87

[[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy. Nuklearmedizin (2003) 0.87

Interaction of the neuroprotective drug riluzole with GABA(A) and glycine receptor channels. Eur J Pharmacol (2001) 0.87

Structural requirements for voltage-dependent block of muscle sodium channels by phenol derivatives. Br J Pharmacol (2001) 0.86

Voltage-dependent block of normal and mutant muscle sodium channels by 4-Chloro-m-Cresol. Br J Pharmacol (1999) 0.86

Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect. J Neurol Neurosurg Psychiatry (2004) 0.85

Coping strategies in episodic and chronic tension-type headache. Headache (2001) 0.85

Guillain-Barré syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c. Infection (2013) 0.85

Modulation of motor evoked potentials by muscle vibration: the role of vibration frequency. Muscle Nerve (1999) 0.85

Emotion/cognition-coupling in word recognition memory of depressive patients: an event-related potential study. Psychiatry Res (2000) 0.84

Botulinum toxin type A and EMG: a key to the understanding of chronic tension-type headaches? Headache (2002) 0.84

Human brain potentials to reading syntactic errors in sentences of different complexity. Neurosci Lett (1997) 0.84

Regulation of bradykinin action at the receptor level. J Cardiovasc Pharmacol (1990) 0.83

Three-dimensional computerized analysis of diadochokinetic movements of Parkinsonian patients. Acta Neurol Scand (2003) 0.83

Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients. Neurol Res (2009) 0.83

Effects of tocainide on normal and myotonic mammalian skeletal muscle. Arzneimittelforschung (1979) 0.83

The cellular mRNA expression of GABA and glutamate receptors in spinal motor neurons of SOD1 mice. J Neurol Sci (2005) 0.83

Pentobarbital has curare-like effects on adult-type nicotinic acetylcholine receptor channel currents. Anesth Analg (2000) 0.82